Current Obstacles Facing Drug Development from Phytocompounds Are Addressed In a Systematic Manner inside New Research 'Modern Phytomedicine: Turning Medicinal Plants into Drugs'.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c43620) has announced the addition of Modern Phytomedicine: Turning Medicinal Plants into Drugs to their offering. This timely and original handbook paves the way to success in plant-based drug development, systematically addressing the issues facing a pharmaceutical scientist who wants to turn a plant compound into a safe and effective drug. Plant pharmacologists from around the world demonstrate the potentials and pitfalls involved, with many of the studies and experiments reported here published for the first time. The result is a valuable source of information unavailable elsewhere. Following a general introduction on the potential and problems of plant-based medicines, the current obstacles facing drug development from phytocompounds are addressed in a systematic manner: quality control, standardization, toxicity, drug delivery and related issues are discussed on a general level and illustrated by real life examples. In the final part, current efforts to develop herbal drugs for different therapeutic fields are presented, again citing practical examples that in some cases include original data never published before. About the author Iqbal Ahmad is a senior lecturer of agricultural microbiology at Aligarh Muslim University Aligarh Muslim University was established by the Indian Muslims and the Act of Indian Parliament made it University. It is located in the city of Aligarh, Uttar Pradesh, India. (AMU amu atomic mass unit. amu abbr. atomic mass unit ), India, and Principal Investigator of the Medicinal Plants Research Project of the University Grant Commission, New Delhi, India. A graduate of AMU, he worked as a research scientist at the Himalaya Drug Company before moving to the AMUs Faculty of Agricultural Sciences. He has so far screened more than 150 traditional Indian medicinal plants for their biological activities and potential prospection. Farrukh Aqil is Project Fellow working on the major research project on medicinal plants at the AMU Department of Agricultural Microbiology. His current work includes biological activities of Indian medicinal plants against MDR MDR, n See multidrug resistance. MDR, n the abbreviation for minimum daily requirement, specifically the Minimum Daily Requirements for Specific Nutrients compiled by the United States Food and Drug Administration. bacteria, antioxidants Antioxidants Substances that reduce the damage of the highly reactive free radicals that are the byproducts of the cells. Mentioned in: Aging, Nutritional Supplements antioxidants, n. , and the antimutagenicity potential of bioactive plant extracts. Mohammad Owais currently holds a faculty position at the Interdisciplinary Biotechnology Unit at Aligarh Muslim University, India. He trained at CDRI CDRI Cooperative Digital Resources Initiative (ATLA) CDRI Central Drug Research Institute (India) CDRI Cambodia Development Resource Institute CDRI Chihuahuan Desert Research Institute , Lucknow and IMTECH IMTECH Institute of Microbial Technology , Chandigarh, and worked during his post doctoral training with Dr. R. C. Gallos group at the NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. , USA. His present work is focusing on the screening of various herbal drugs for their potential to treat drug resistant infections, and developing and applying drug delivery systems to herbal drugs to assess the efficacy, stability and toxicity in animal models. Content Outline: * Bioactive Phytocompounds (BPs): New Approach on Modern Phytoscience * Quality Control, Screening, Toxicity and Regulations of Herbal Drugs * Herbal Medicine herbal medicine, use of natural plant substances (botanicals) to treat and prevent illness. The practice has existed since prehistoric times and flourishes today as the primary form of medicine for perhaps as much as 80% of the world's population. : Prospects and Constraints * Bioactive Phytocompounds and Products Traditionally used in Japan * Plant Extracts used to manage Bacterial, Fungal and Parasitic Infections in Southern Africa * Biological and Toxicological Properties of Moroccan Plant Extracts * Anti-MRSA and Anti-VRE Activities of Phytoalexin Phytoalexin Any antibiotic produced by plants in response to microorganisms. Plants use physical and chemical barriers as a first line of defense. When these barriers are breached, however, the plant must actively protect itself by employing a variety of and Phytoncide Isolated from Tropical Plants * Methods for Testing the Antimicrobial Activity of Extracts * Targeted Screening of Bioactive Plant Extracts and Phytocompounds * Activity of Plant Extracts and Plant-derived Compounds against Drug-resistant Microorganisms * Alternative Holistic Medicinal Approach in Total Management of Hepatic Disorders * Traditional Plant and Herbal Remedies Used in the Treatment of Diarrhoeal Disease * Mutagenicity mutagenicity /mu·ta·ge·nic·i·ty/ (-je-nis´it-e) the property of being able to induce genetic mutation. mutagenicity the property of being able to induce genetic mutation. and Antimutagenic Potentials of Plant Extracts and Phytocompound * Potential of Plant-derived Products in the Treatment of Mycobacterial mycobacterial emanating from or pertaining to mycobacterium. mycobacterial granuloma may be caused by Mycobacterium tuberculosis (see cutaneous tuberculosis), M. Infections * Ethnomedicinal Antivirals: Scope and Opportunity * Immunomodulatory Effects of Phytocompounds * Use of Liposomal Delivery System for Herbal-based Therapeutics For more information visit http://www.researchandmarkets.com/reports/c43620 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion